The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist
Abstract
Objective: Recurrent digital ulcers are a manifestation of vascular disease in patients with systemic sclerosis (SSc; scleroderma) and lead to pain, impaired function, and tissue loss. We investigated whether treatment with the endothelin receptor antagonist, bosentan, decreased the development of new digital ulcers in patients with SSc. Methods: This was a randomized, prospective, placebo‐controlled, double‐blind study of 122 patients at 17 centers in Europe and North America, evaluating the effect of treatment on prevention of digital ulcers. The primary outcome variable was the number of new digital ulcers developing during the 16‐week study period. Secondary assessments included healing of existing digital ulcers and evaluation of hand function using the Scleroderma Health Assessment Questionnaire. Results: Patients receiving bosentan had a 48% reduction in the mean number of new ulcers during the treatment period (1.4 versus 2.7 new ulcers; P = 0.0083). Patients who had digital ulcers at the time of entry in the study were at higher risk for the development of new ulcers; in this subgroup the mean number of new ulcers was reduced from 3.6 to 1.8 (P = 0.0075). In patients receiving bosentan, a statistically significant improvement in hand function was observed. There was no difference between treatment groups in the healing of existing ulcers. Serum transaminase levels were elevated to >3‐fold the upper limit of normal in bosentan‐treated patients; this elevation is comparable with that observed in previous studies of this agent. Other side effects were similar in the 2 treatment groups. Conclusion: Endothelins may play an important role in the pathogenesis of vascular disease in patients with SSc. Treatment with the endothelin receptor antagonist bosentan may be effective in preventing new digital ulcers and improving hand function in patients with SSc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-95 · Cited by 3,950
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationInoue, A., Yanagisawa, M., Kimura, S., Kasuya, Y., Miyauchi, T., Goto, K., & Masaki, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2863 · Cited by 2,517
Badesch, D. B., Tapson, V. F., McGoon, M. D., Brundage, B. H., Rubin, L. J., Wigley, F. M., Rich, S., Barst, R. J., Barrett, P. S., Kral, K. M., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-6-200003210-00002 · Cited by 1,075
FERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00004 · Cited by 764
Steen, V. D., & Medsger, T. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401110 · Cited by 504
Kourembanas, S., McQuillan, L. P., Leung, G. K., & Faller, D. V. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116604 · Cited by 445
Wigley, F. M., Wise, R. A., Seibold, J. R., McCloskey, D. A., Kujala, G., Medsger, T. A., Steen, V. D., Varga, J., Jimenez, S., Mayes, M., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00004 · Cited by 421
Self-citationPathogenesis of systemic sclerosis: A vascular hypothesis
Campbell, P. M., & LeRoy, E. C. (1975) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(75)90017-7 · Cited by 413
Cited by
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citationAllanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.2 · Cited by 876
Self-citationKowal-Bielecka, O., Landewé, R., Avouac, J., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096677 · Cited by 619
Self-citationVolkmann, E. R., Andréasson, K., & Smith, V. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01692-0 · Cited by 616
Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24038 · Cited by 615
Matucci-Cerinic, M., Denton, C. P., Furst, D. E., Mayes, M. D., Hsu, V. M., Carpentier, P., Wigley, F. M., Black, C. M., Fessler, B. J., Merkel, P. A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.130658 · Cited by 498
Self-citationWigley, F. M., & Flavahan, N. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507638 · Cited by 420
Pathogenesis of Raynaud's phenomenon
Herrick, A. L. (2005) · Rheumatology · doi:10.1093/rheumatology/keh552 · Cited by 408
Self-citationTransforming growth factor β—at the centre of systemic sclerosis
Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 332
Varga, J., Trojanowska, M., & Kuwana, M. (2017) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000249 · Cited by 323
Barton, M., & Yanagisawa, M. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-059 · Cited by 305
The pathogenesis, diagnosis and treatment of Raynaud phenomenon
Herrick, A. L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.96 · Cited by 302
Self-citationInvolvement of functional autoantibodies against vascular receptors in systemic sclerosis
Riemekasten, G., Philippe, A., Näther, M., Slowinski, T., Müller, D. N., Heidecke, H., Matucci-Cerinic, M., Czirják, L., Lukitsch, I., Becker, M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135772 · Cited by 302
Self-citationEndothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 295
TGFβ, cardiac fibroblasts, and the fibrotic response
LEASK, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.012 · Cited by 265
Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C. P., Rudnicka, L., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14458 · Cited by 261
Self-citationTrials and tribulations of skin iontophoresis in therapeutics
Roustit, M., Blaise, S., & Cracowski, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12128 · Cited by 136
Vascular involvement in systemic sclerosis (scleroderma)
Postlethwaite, Pattanaik, D., & Brown, M. (2011) · Journal of Inflammation Research · doi:10.2147/jir.s18145 · Cited by 119
Lagares, D., García‐Fernández, R. A., Jiménez, C. L., Magán‐Marchal, N., Busnadiego, O., Lamas, S., & Rodríguez‐Pascual, F. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27307 · Cited by 80
Metadata
- Authors
- Korn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., Hsu, V., Guillevin, L., Chatterjee, S., Peter, H. H., Coppock, J., Herrick, A., Merkel, P. A., Simms, R., Denton, C. P., Furst, D., Nguyen, N., Gaitonde, M., Black, C., & RAPIDS‐1 Study Group
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 50
- Issue
- 12
- Pages
- 3985-3993
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2118846800
- Cited by
- 728
- References
- 22
- FWCI
- 24.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.